"We will work closely with AstraZeneca for COVID-19 vaccine distribution"- Adar Poonawalla
05 June 2020 | Views
Adar Poonawalla, Chief Executive Officer, Serum Institute of India, Pune shares the latest contribution of his company towards the COVID-19 fight
“Serum Institute of India (SII) is delighted to partner with AstraZeneca in bringing the Oxford vaccine to India as well as low and middle-income countries. Over the past 50 years SII has built significant capability in vaccine manufacturing and supply globally. We will work closely with AstraZeneca to ensure fair and equitable distribution of the vaccine in these countries.”
Adar Poonawalla, Chief Executive Officer, SII, Pune
